Track: Cardio-Oncology

Cardio Care Conference 2025

The "Cardio-Oncology" session will delve into the critical intersection of heart disease and cancer, highlighting the latest advancements in diagnosing and managing cardiovascular complications in cancer patients. The session will focus on the impact of cancer treatments—such as chemotherapy, radiation, and targeted therapies—on the heart, exploring the long-term risks and challenges these treatments present. It will also cover innovative strategies for preventing and managing heart conditions in cancer patients, with an emphasis on personalized care approaches tailored to individual risk factors. By integrating advanced imaging techniques and biomarkers, the session will showcase how early detection and precision medicine are improving outcomes. 

Chemotherapy and Radiation-Induced Cardiovascular Disease: Understanding the mechanisms of cardiovascular toxicity caused by chemotherapy and radiation therapies, and the management of conditions such as heart failure, myocardial infarction, and arrhythmias in cancer patients.

Cardiovascular Toxicity of Cancer Therapies: Discover how certain cancer treatments, such as anthracyclines, trastuzumab, radiation therapy, and newer immunotherapies, can lead to cardiovascular complications like heart failure, arrhythmias, and vascular damage. Understand the mechanisms of these toxicities and the role of early intervention to prevent long-term heart damage.

Early Detection and Monitoring in Cardio-Oncology: Learn about the strategies for early detection of cardiovascular risks in cancer patients, including the use of echocardiography, biomarkers, cardiac MRI, and multigated acquisition (MUGA) scans. Understand how continuous monitoring throughout cancer treatment can help detect early signs of heart damage and guide timely intervention.

Managing Cardiovascular Risk in Cancer Patients: Explore treatment approaches for managing cardiovascular risk in patients undergoing cancer treatment. Discuss the role of medications such as ACE inhibitors, beta-blockers, and statins in preventing and mitigating the cardiac side effects of cancer therapies. Learn how lifestyle interventions, including nutrition and physical activity, are incorporated into patient care.

Heart Failure in Cancer Survivors: Discuss the pathophysiology, diagnosis, and management of heart failure in cancer survivors, particularly in those who have received chemotherapy or radiation therapy. Understand the unique challenges in treating heart failure in this population, including the balance between cardiovascular and cancer care.

Cardiac Rehabilitation in Cancer Patients: Explore the role of cardiac rehabilitation programs in cancer patients to improve heart health and quality of life during and after cancer treatment. Learn how these programs can help reduce cardiovascular risk, improve physical function, and support emotional well-being.

Pediatric Cardio-Oncology: Gain insights into the unique challenges of pediatric cardio-oncology, particularly in children who receive cancer treatments at a young age. Discuss long-term cardiovascular monitoring strategies and approaches to minimizing the risk of cardiovascular disease in pediatric cancer survivors.

Emerging Therapies and Innovations in Cardio-Oncology: Discover the latest advances in cardio-oncology, including new medications, therapies, and clinical trials focused on preventing or reversing cardiovascular damage caused by cancer treatments. Discuss the potential of gene therapy, stem cell therapy, and biomarkers in early detection and personalized treatment strategies.

Submit an abstract to contribute to discussions driving innovation in cardio-oncology. Your insights are crucial to advancing global heart cancer care initiatives.